Vice Provost and Dean of Research
Showing 61-70 of 99 Results
-
Patricia Rodriguez Espinosa
Assistant Professor of Epidemiology and Population Health
BioDr. Patricia Rodriguez Espinosa, PhD., MPH, is an Assistant Professor in the Department of Epidemiology and Population Health and also serves as the Associate Director of Research for the Office of Community Engagement at Stanford Medicine. Dr. Rodriguez Espinosa is also the Associate Core Lead for the Outreach, Recruitment, and Engagement Core of the Stanford Alzheimer's Disease Research Center. The ultimate goal of her research is to improve the health of diverse populations - including Latinxs, under-resourced communities, and older adults - through transdisciplinary and community-engaged scholarship. Her research aims to develop novel multi-level interventions and health promotion programs to improve health outcomes (e.g., around aging, multiple chronic conditions, cardiovascular disease) and that include multi-sectoral collaborations. Dr. Rodriguez Espinosa's research has also centered around developing the science of Community-Based Participatory Research, citizen/community science, and other participatory research approaches.
-
Kacper Rogala
Assistant Professor of Structural Biology and of Chemical and Systems Biology
Current Research and Scholarly InterestsOur team is fascinated by how cells make growth decisions — to grow or not to grow. In order to grow, cells require nutrients, and we are unraveling how cells use specialized protein sensors and transporters to sense and traffic nutrients in between various compartments. We use approaches from structural biology, chemical biology, biophysics, biochemistry, and cell biology — to reveal the mechanisms of basic biological processes, and we develop chemical probes that modulate them.
-
Angela Rogers
Professor of Medicine (Pulmonary and Critical Care)
Current Research and Scholarly InterestsWe use genetics and genomics methodologies to identify novel ARDS pathobiology; we hope that this will enable identification of novel biomarkers, phenotypes, and treatments for the disease. We are building a plasma biobank of critically ill patients at Stanford, with a particular focus on metabolic changes in critical illness.
-
Eugene Y. Roh, MD
Clinical Associate Professor, Orthopaedic Surgery
Current Research and Scholarly InterestsTherapeutic Efficacy of biologic treatments(Platelet Rich Plasma, adipose, mfat, bone marrow, stem cell) in OA and tendonitis
Application of musculoskeletal ultrasound for sports medicine and other musculoskeletal disease.
AI-based musculoskeletal diagnosis and treatment in sports, OA and tendinitis -
Rajat Rohatgi
Professor of Biochemistry and of Medicine (Oncology)
Current Research and Scholarly Intereststhe overall goal of my laboratory is to uncover new regulatory mechanisms in signaling systems, to understand how these mechanisms are damaged in disease states, and to devise new strategies to repair their function.
-
Milenia Rojas Mendoza
Ph.D. Student in Chemical Engineering, admitted Autumn 2022
OTL Intern, Office of Technology Licensing (OTL)BioMilenia Rojas (she/her) is a PhD candidate in the Chemical Engineering Department at Stanford University. She is advised by Thomas Jaramillo. Milenia's research focuses on integrating cost-effective, earth-abundant metal catalysts into membrane electrode assembly water electrolyzers for hydrogen production. Her goal is to reduce production costs, extend lifespan, and enhance scalability to support the energy transition. She is part of the Emerson Consequential Scholars Program and works part time at the office of technology transfer. She graduated in 2022 with a Bachelor's in Chemical Engineering from the University of Rochester.
-
Julie Marie Romero
Industrial Contract Associate, Office of Technology Licensing (OTL)
Current Role at StanfordProject Manager 1 - General, Industry Relations
-
Maria Grazia Roncarolo
George D. Smith Professor of Stem Cell and Regenerative Medicine, Emerita
Current Research and Scholarly InterestsResearch Interests
Immunetolerance: Mechanisms underlying T-cell tolerance, induction of T-cell anergy and regulatory T cells; Immunomodulation: mAbs, proteins and low molecular weight compounds which can modulate T-cell activation; Primary immunodeficiencies: Characterization of molecular and immunological defects; Gene therapy: Gene transduction of hematopoietic cells for gene therapy in primary immunodeficiencies and metabolic diseases; Hematopoiesis: Mechanisms underlying growth and differentiation of hematopoietic stem cells; Transplantation: Immune reconstitution and T-cell tolerance after allogenic stem cell transplantation; Cytokines/Cytokine receptors: Role in regulation of immune and inflammatory responses
Clinical Interests
Primary Immunodeficiencies
Monogenic Autoimmune Disorders
Allogenic Bone Marrow Transplantation
Gene Therapy Clinical Trials
Cell Therapy Clinical Trials
Clinical Trials in Autoimmune Diseases and Organ Transplantation
Clinical Trials in Hemoglobinopathies
